Lv1
80 积分 2025-09-17 加入
Engineering IL-2 for immunotherapy of autoimmunity and cancer
1个月前
已完结
Assessing the toxicity of bispecific antibodies
1个月前
已完结
Targeting Solid Tumors Using CD3 Bispecific Antibodies
2个月前
已完结
T cell-engaging therapies — BiTEs and beyond
3个月前
已完结
Harnessing cytokines and chemokines for cancer therapy
3个月前
已完结
Primordial prevention of cardiovascular disease
5个月前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
6个月前
已完结
The present and future of bispecific antibodies for cancer therapy
6个月前
已完结
皖公网安备34019202002308
